YOUR BUSINESS AUTHORITY
Springfield, MO
Amgen Inc. agreed to buy Celgene Corp.'s psoriasis treatment called Otezla for $13.4 billion.
The deal allows Bristol-Myers Squibb Co. to move forward on its acquisition of Celgene.
Otezla's sales were $1.6 billion last year.
Read more from The Wall Street Journal.
For 25 years, Springfield Business Journal has honored local women for their professional and civic accomplishments and contributions.
Updated: Jason Gage to resign as city manager
Downtown business owners pen letter critical of Route 66 Festival
Construction to start this month on restaurant at historic mill site
Apartments planned at century-old building in downtown Springfield
American Airlines adds seasonal Miami flight at Springfield airport